Literature DB >> 3446541

Botulinum toxin A induced protective ptosis.

G G Adams1, C M Kirkness, J P Lee.   

Abstract

Botulinum Toxin A injected into the levator palpebrae superioris produces a flaccid ptosis of the upper lid and provides a safe and effective protection for the cornea to aid healing in indolent ulceration or as prophylaxis when there is fifth or seventh cranial nerve damage. Fifteen patients have received this treatment. Levator paresis, producing ptosis for a mean of 2-3 weeks and recovering in a mean of 8.1 weeks was successfully produced in all patients and complete corneal healing was produced in 80% of patients. The major side effect was weakness of the superior rectus muscle which occurred in 80% of cases and lasted a mean of 6 weeks.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3446541     DOI: 10.1038/eye.1987.93

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  [Botulinum toxin injection for production of ptosis].

Authors:  R-L Merté; I M Lanzl
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

2.  [Drug therapy and radiotherapy in Graves' orbitopathy].

Authors:  F Beisse; W A Lagrèze; M Schmucker
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

3.  [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].

Authors:  A Schilimow; B Wiechens
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

4.  Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.

Authors:  P Corridan; S Nightingale; N Mashoudi; A C Williams
Journal:  Br J Ophthalmol       Date:  1990-05       Impact factor: 4.638

5.  Use of Botulinum Toxin in Ophthalmology.

Authors:  Michael J Wan; Sara AlShaker; David G Hunter
Journal:  Handb Exp Pharmacol       Date:  2021

6.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

7.  Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease.

Authors:  J M Olver
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

8.  [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease].

Authors:  T Dintelmann; J Sold; F Grehn
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

9.  Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.

Authors:  Thomas Fuchsluger; Emre Tuerkeli; Henrike Westekemper; Joachim Esser; Klaus-Peter Steuhl; Daniel Meller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535

Review 10.  [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].

Authors:  B Wabbels; M Förl
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.